Attached files
file | filename |
---|---|
EX-31.8 - EXHIBIT 31.8 - Sorrento Therapeutics, Inc. | v468942_ex31-8.htm |
EX-10.31 - EXHIBIT 10.31 - Sorrento Therapeutics, Inc. | v468942_ex10-31.htm |
10-K/A - 10-K/A - Sorrento Therapeutics, Inc. | v468942_10ka.htm |
Exhibit 31.7
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Henry Ji, certify that:
1. | I have reviewed this Amendment No. 3 to Annual Report on Form 10-K/A of Sorrento Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: June 26, 2017 | By: | /s/ Henry Ji | |
Henry Ji | |||
President and Chief Executive Officer | |||
(Principal Executive Officer) |